Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Newborn screening for Duchenne muscular dystrophy.

H Zellweger, A Antonik

    Pediatrics
    |January 1, 1975
    PubMed
    Summary

    A new dried blood spot test can reliably detect elevated creatinephosphokinase (CPK) in newborns, enabling early diagnosis of Duchenne muscular dystrophy (DMD) for timely supportive care and carrier identification.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    About chronic abacterial meningitis.

    Annales paediatrici. International review of pediatrics·2010
    Same author

    About muscle hypotension.

    Annales paediatrici. International review of pediatrics·2010
    Same author

    Considerations on the 1944 poliomyelitis epidemic.

    Schweizerische medizinische Wochenschrift·2010
    Same author

    Sporadic case of constitutional, macrocytic anemia (Fanconi) in a 12 year old boy from a healthy family.

    Annales paediatrici. International review of pediatrics·2010
    Same author

    About two cases of congenital relaxation diaphragm with special consideration of the abdominal site.

    Helvetica paediatrica acta·2010
    Same author

    Twice poliomyelitis.

    Praxis·2010

    Area of Science:

    • Biochemistry
    • Genetics
    • Pediatrics

    Background:

    • Duchenne muscular dystrophy (DMD) affects 1 in 3,000-4,000 boys.
    • Elevated creatinephosphokinase (CPK) is a key indicator, present from birth in DMD patients.
    • Distinguishing DMD-related CPK elevation from transient newborn levels is crucial.

    Purpose of the Study:

    • To introduce a reliable method for determining CPK levels in dried blood spots.
    • To establish a screening procedure suitable for newborn infants.

    Main Methods:

    • Development of a new assay for creatinephosphokinase (CPK) measurement.
    • Utilizing dried blood samples for neonatal screening.

    Main Results:

    • The described method reliably quantifies CPK in a small blood sample.
    • The assay meets established criteria for newborn screening.

    Conclusions:

    • Early DMD diagnosis via reliable CPK screening is feasible in newborns.
    • Early detection facilitates supportive treatment and identification of female carriers.
    • Implementation of this screening method for male newborns is recommended.

    Related Experiment Videos